Study Evaluating the Safety and Effects of MN-221 in Subjects With Moderate to Severe Asthma
Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and tolerability of MN-221 at two
different dosing rates administered through a continuous infusion in subjects diagnosed with
moderate to severe asthma.